Based on analysis of TCGA database, high expression of RACGAP1 is significantly associated with breast cancer, lung adenocarcinoma, papillary renal cell carcinoma, hepatocellular carcinoma and cutaneous melanoma. This evidence concerns the gene RACGAP1 and papillary renal cell carcinoma.